Does low serum 25-hydroxyvitamin D increase insulin resistance and risk of type 2 diabetes?

Clinical and epidemiological evidence

• Prospective cohort studies and meta-analyses consistently demonstrate a strong inverse relationship between circulating serum 25-hydroxyvitamin D [25(OH)D] levels and the risk of developing type 2 diabetes.
• Longitudinal observational data indicate that individuals with sufficient baseline vitamin D levels have a significantly lower future risk of diabetes. For example, a large prospective cohort study reported a hazard ratio of 0.48 (95% CI 0.26–0.88) for the highest compared to the lowest quartile of predicted vitamin D levels.
• Clinically, vitamin D-deficient individuals exhibit poorer glycemic control and significantly higher Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) values than their vitamin D-sufficient peers. However, randomized controlled trials of vitamin D supplementation have yielded mixed results; one large trial in high-risk, non-diabetic adults reported a non-significant risk reduction of 12% (HR 0.88, 95% CI 0.75–1.04).

Mechanistic explanations

• Vitamin D is directly involved in glucose metabolism through its interaction with the vitamin D receptor (VDR) on pancreatic β-cells, where it facilitates calcium influx to promote insulin synthesis and secretion. Low 25(OH)D status consequently impairs β-cell performance and reduces active insulin release.
• Vitamin D regulates systemic inflammation by suppressing pro-inflammatory cytokines (such as TNF-α and IL-6) and downregulating NF-κB pathways. Chronic, low-grade inflammation is a primary driver of peripheral insulin resistance in skeletal muscle and adipose tissue, meaning deficiency indirectly exacerbates tissue resistance.
• Active vitamin D stimulates the expression of insulin receptors and insulin receptor substrates in peripheral tissues, which directly enhances cellular glucose uptake.

Bottom line

Low serum 25-hydroxyvitamin D is strongly and consistently associated with higher insulin resistance and an increased risk of type 2 diabetes in large observational studies. While the underlying biological mechanisms—including pancreatic β-cell support and anti-inflammatory activity—are well-established, clinical trials suggest that vitamin D supplementation alone may have a modest or non-significant effect on preventing progression to diabetes in broad, high-risk populations, emphasizing the importance of correcting deficiency early alongside overall metabolic management.